Lumanity

Therapeutic Science and Strategy

Science EN ↓ Odcinki: 27

In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: sites.libsyn.com

Autor

Lumanity

Kategoria

Science

Strona podcastu

sites.libsyn.com

Ostatni odcinek

9 lip 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

CAR-T in Solid Tumors: A Cancer Progress Sneak Peek 25.04.2022 22:47

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this second episode, Joel sits down with Shivani Srivastava, PhD, Assistant Professor Human Biology Division, Fred Hutchinson Cancer Research Center , to explore: Key challenges to addressing solid tumors with cell therapy Recent developments (technology, scientifi...

Not So Rare: Win-wins in Ultra-orphan Diseases 25.02.2022 18:40

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this first episode, Joel sits down with Michael Parisi, CEO of Guidemark, and Michael Rice, Vice President, Head of Advanced Therapeutics, to explore: How uncovering NSCLC and SMA genetics led to record-speed options for patients with rare subtypes How the patient a...